RBC Capital raised the firm’s price target on Teleflex (TFX) to $135 from $130 and keeps a Sector Perform rating on the shares following Q2 results. RBC Capital views Q2 results favorably but noted that Teleflex underlying organic constant currency revenue growth is still tracking to 1%-2% year-over-year and EPS growth at approximately up 50 basis points, the firm told investors. RBC added that the valuation reflects this even as the firm expects expect acceleration into the second half.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
- Teleflex Raises 2025 Guidance After BIOTRONIK Acquisition
- Teleflex reports Q2 adjusted EPS $3.73, consensus $3.37
- Teleflex raises FY25 adjusted EPS view to $13.90-$14.30 from $13.20-$13.60
- Teleflex price target lowered to $130 from $150 at Mizuho
- Teleflex reports results from study of Arrow Chlorhexidine-Impregnated CVCs